Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Laboratory Corporation of America Holdings (NYSE:LH)

Delayed Data
As of Sep 30
 +2.02 / +1.49%
Today’s Change
Today|||52-Week Range
Health Services
Services to the Health Industry

Company Description

Laboratory Corp. of America Holdings operates as an independent clinical laboratory company. The company operates in Clinical diagnostics laboratory segment and Other segment. The Clinical diagnostics laboratory segment includes core testing as well as genomic and esoteric testing. The Other segment comprised of the company's non-U.S. clinical diagnostic laboratory operations in Ontario, Canada. Its national network of laboratories offers a broad range of clinical laboratory tests that are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease. The company's specialty testing operations comprises of oncology testing, HIV genotyping and phenotyping, diagnostic genetics and clinical trials. It also provides specialty testing services in the areas of allergy, clinical trials, diagnostic genetics, identity, forensics, infectious disease, oncology and occupational testing. The company was founded in 1971 and is headquartered in Burlington, NC.

Contact Information

Laboratory Corp. of America Holdings
358 South Main Street
Burlington North Carolina 27215-5837
P:(336) 229-1127
Investor Relations:
(336) 436-5076



Other institutional51.55%
Mutual fund holders46.44%
Individual stakeholders1.03%

Top Executives

David P. KingChairman, President & Chief Executive Officer
Glenn A. EisenbergChief Financial Officer, Treasurer & Executive VP
Marcia T. EisenbergChief Scientific Officer & Senior Vice President
Mark Elliott BrecherChief Medical Officer & Senior Vice President
Lance V. BerberianChief Information Officer & Senior Vice President